Annovis Bio, Inc.
ANVSNYSECIK 1477845HealthcareFiscal year ends Dec 31
Reports and events: 131 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-07-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-080039 |
| 2024-07-1016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-078937 |
| 2024-07-0208:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-077093 |
| 2024-06-1306:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-071011 |
| 2024-06-1117:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-070450 |
| 2024-06-0516:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-068701 |
| 2024-05-2116:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-063829 |
| 2024-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060518 |
| 2024-05-1017:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007820 |
| 2024-05-0916:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-059315 |
| 2024-05-0617:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-057525 |
| 2024-05-0216:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-006534 |
| 2024-05-0117:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-055838 |
| 2024-04-2917:10 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001104659-24-054167 |
| 2024-04-2608:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-052471 |
| 2024-04-0318:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-042695 |
| 2024-03-2917:12 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004393 |
| 2024-03-2217:24 ET | 8-K | 8.01 Other events | 0001104659-24-037958 |
| 2024-03-2117:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-037406 |
| 2024-03-2016:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-036742 |
| 2024-03-2021:20 ET | 8-K | 8.01 Other events | 0001104659-24-036331 |
| 2024-03-1517:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-035082 |
| 2023-11-0816:45 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018298 |
| 2023-11-0112:28 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-113281 |
| 2023-10-3017:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-112633 |
| 2023-10-1319:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-108892 |
| 2023-08-1416:40 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014884 |
| 2023-06-1616:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-072250 |
| 2023-05-3017:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-23-066171 |
| 2023-05-1016:34 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009142 |
| 2023-04-2808:00 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001104659-23-052107 |
| 2023-04-0408:39 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001104659-23-041237 |
| 2023-04-0317:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-041009 |
| 2023-04-0307:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-040537 |
| 2023-03-3116:58 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001104659-23-040275 |
| 2023-03-3109:18 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-23-039748 |
| 2023-03-0617:02 ET | 8-K | 4.02 Non-reliance on financial statements | 0001104659-23-029078 |
| 2023-02-1314:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-019581 |
| 2023-01-0616:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-001850 |
| 2022-11-0816:44 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016902 |
| 2022-09-1217:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-099298 |
| 2022-08-3006:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-095769 |
| 2022-08-0811:44 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-012561 |
| 2022-08-0808:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086948 |
| 2022-06-0308:54 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-067880 |
| 2022-05-0411:42 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-006981 |
| 2022-05-0408:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-055573 |
| 2022-04-1816:11 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001104659-22-046860 |
| 2022-03-0216:12 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-002668 |
| 2021-11-1514:33 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-139005 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:17 ET. Listed shows no prices and gives no investment advice.